Results 241 to 250 of about 416,036 (340)
ABSTRACT Indole and thiazole derivatives have garnered significant attention due to their potent antitumor activities. Encapsulation of such derivatives into polymeric nanoparticles offers several advantages, including improved molecular stability and targeted delivery to tumor sites, thereby enhancing their antineoplastic potential.
José Cleberson Santos Soares +4 more
wiley +1 more source
Cisplatin resistance in head and neck squamous cell carcinoma is linked to DNA damage response and cell cycle arrest transcriptomics rather than poor drug uptake. [PDF]
Sandu K +7 more
europepmc +1 more source
A simple and efficient design strategy for the synthesis of BODIPY‐linked N‐Heterocyclic Carbene Metal Complexes (Ag, Cu, Ni, Pd) is developed. Fluorescent BODIPY‐silver carbene complex is useful for cellular imaging and shows chemotheraputic anti‐cancer activity.
Shraddha SP Yadav +6 more
wiley +1 more source
The molecular mechanisms of mitochondrial dynamics and mitophagy and their complex association with cancer drug resistance. [PDF]
Zhao Z, Ren Y, Yuan M, Liu G, Sun J.
europepmc +1 more source
ABSTRACT OCT4 plays a crucial role in the DNA damage response(DDR) mechanism, whereas cisplatin (CDDP) acts as an anti‐tumor agent by inducing DDR. This study aimed to investigate the role of OCT4 in regulating DNA methyltransferase 1 (DNMT1) in CDDP‐treated gastric cancer (GC).
Zhengzheng Yan +6 more
wiley +1 more source
The synergistic action of HDAC inhibitor with cisplatin impedes survival and proliferation of drug-tolerant persister in gastric and liver cancer cells. [PDF]
Singh A +7 more
europepmc +1 more source
The effect of cisplatin dacarbazine vindesine therapy for progressive stage malignant melanoma.
Naoya Yamazaki +3 more
openalex +2 more sources
Pharmacokinetics of teicoplanin in paediatric patients—A systematic review of current literature
Background and Objective Teicoplanin is commonly used in children to treat gram‐positive infections and is sometimes used off‐label prophylactically in surgical or paediatric oncology settings. The pharmacokinetics (PK) of teicoplanin in children exhibit considerable variability, such as in critically ill children or those with renal impairment.
Noa E. Wijnen +4 more
wiley +1 more source

